# Medopad funding: rounds and investors

> Medopad has raised $54M across 5 rounds since 2012. Investors include Bayer, Intel and Vodafone. Every round with its source.

Source: https://millionrounds.com/company/medopad (Millionrounds; every figure on the page links to its filing or article)

United Kingdom · [Series B startup](https://millionrounds.com/companies)

# Who invested in *Medopad*

5 rounds we have observed, with the 4 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech Healthcare

Funding summary Updated 26 Oct 2026

**$54M** raised across 5 rounds since 2012, from 5 sources

**$1.1M** Round **$1.0M** Seed **$700K** Round **$26M** Series A **$25M** Series B

- **Latest round:** Series B, $25M Nov 2019
- **Led by:** Bayer
- **Biggest round:** $26M Series A · Feb 2018
- **Investors:** 4 (1 led)

See who backed them

## The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

2012 2013 2014 2015 2016 2017 2018 2019

**$1.1M** Round

**$1.0M** Seed

**$700K** Round

**$26M** Series A

**$25M** Series B

- **First round:** Round, $1.1M
- **Biggest round:** $26M
- **Usual gap between rounds:** 21 months

## The rounds

- **Nov 2019** Series B **$25M** *1 new* [Bayer](https://millionrounds.com/fund/bayer) Lead Reported by TechCrunch
- **Feb 2018** Series A **$26M** *1 new* China’s NWS Holdings Reported by FinSMEs
- **Mar 2014** Round **$700K** *2 new* [Intel](https://millionrounds.com/fund/intel) [Vodafone](https://millionrounds.com/fund/vodafone-ventures) From a historical funding record
- **Jun 2013** Seed **$1.0M** No investor was named in the report. From a historical funding record
- **Jan 2012** Round **$1.1M** No investor was named in the report. From a historical funding record

## Funding filed with regulators

Medopad filed 11 raises, $163M in all. Filings say how much was sold and to how many investors; they never name the investors.

- Apr 2025 **$17M** UK share allotment
- Sept 2024 **$12M** UK share allotment
- Sept 2024 **$6.8M** UK share allotment
- Apr 2024 **$643K** UK share allotment
- Mar 2024 **$4.0M** UK share allotment
- Sept 2023 **$32M** UK share allotment
- Jun 2023 **$20M** UK share allotment
- May 2022 **$240K** UK share allotment
- May 2022 **$7.4M** UK share allotment
- May 2022 **$24M** UK share allotment
- Jul 2021 **$38M** UK share allotment

## Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

**Round** 2012 **Seed** 2013 **Round** 2014 **Series A** 2018 **Series B** 2019 [Bayer](https://millionrounds.com/fund/bayer) L [Intel](https://millionrounds.com/fund/intel) [Vodafone](https://millionrounds.com/fund/vodafone-ventures) China’s NWS Holdings

## Everyone who backed them

[Bayer](https://millionrounds.com/fund/bayer) Corporate VC **1** round, led 1

[Intel](https://millionrounds.com/fund/intel) Growth equity **1** round

[Vodafone](https://millionrounds.com/fund/vodafone-ventures) VC firm **1** round

China’s NWS Holdings no record of our own yet **1** round

Missing a round, or an investor who was in one? [Tell us](https://millionrounds.com/corrections?slug=medopad).

## Quick answers about Medopad

### Who invested in Medopad?

Medopad's investors include Bayer, Intel, Vodafone and China’s NWS Holdings. Bayer led its latest round.

### How much has Medopad raised?

Medopad has raised $54M across 5 rounds since 2012.

### When did Medopad last raise?

Medopad's most recent round was a Series B of $25M in Nov 2019, led by Bayer.

### What was Medopad's biggest round?

Medopad's largest round on record is $26M (Series A), in Feb 2018.

### Who backed Medopad first?

Medopad's first round on record, in Mar 2014, was backed by Intel and Vodafone.

### What stage is Medopad at?

Medopad's latest named round is a Series B, in Nov 2019.

### Where is Medopad based?

Medopad is based in the United Kingdom.

### Who led Medopad's rounds?

Bayer led the Series B in 2019.

## Companies like Medopad

In the same sector, and raised in the last eighteen months.

[**Coherence Neuro** $55M · Oct 2026](https://millionrounds.com/company/coherence-neuro)[**HydRegen** $12M · Oct 2026](https://millionrounds.com/company/hydregen)[**XRlabs** $8.4M · Oct 2026](https://millionrounds.com/company/xrlabs)[**OMass Therapeutics** $442M · Oct 2026](https://millionrounds.com/company/omass-therapeutics)[**CMR Surgical** $1.1B · Oct 2026](https://millionrounds.com/company/cmr-surgical)[**MintNeuro** $26M · Oct 2026](https://millionrounds.com/company/mintneuro)

## Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.

Open the investor searchOr these rounds in the app
